CME Science Advanced PET Imaging, Nuclear Medicine, and Therapy From Diagnostics to Theranostics 2025

• Target Audience: practicing radiologists, nuclear medicine physicians and radiologic nurses, physician assistants
• Sample video: contact me for sample video
• Information:

This course provides a clinical perspective of PET/CT imaging and the emerging use of Theranostic agents within Nuclear Medicine. A broad perspective on the economic, clinical, and academic aspects of the latest trends in PET/CT imaging and Nuclear Medicine therapy will be presented.

Target Audience

This course is intended for practicing radiologists, nuclear medicine physicians and radiologic nurses, physician assistants, technologists, residents, fellows and others who are interested in the clinical applications of PET and PET/CT.

Course Objectives

At the conclusion of this course, participants will be able to:

• Describe new developments in the merger of diagnostic and therapeutic radioligands for PET/CT imaging and therapy with specific focus on DOTA, PSMA, and PRRT

• Describe the logistics of bringing these new diagnostic and therapeutic technologies to clinical practice

• Identify the key clinical indications for new emerging tracers for Neuroendocrine Tumor and Prostate cancer using somatostatin receptor and PSMA PET/CT imaging

• Topics:

Thursday, October 16, 2025

Time

Session

Speaker

Check-In and Continental Breakfast, Mouton Meeting Room

Introduction to Theranostics

Phillip Kuo, MD, PhD

Update on Radioiodine Treatment for Thyroid Cancer and the Role of PET/CT

Don C. Yoo, MD

Questions and Answers, Coffee Service

Importance of Patient Preparation for PET/CT (Oncology and Cardiac Sarcoidosis)

Don C. Yoo, MD

PET/CT in Head and Neck Cancer

Don C. Yoo, MD

Questions and Answers

Luncheon Sponsored by Lantheus, Alsace Room

Dopamine Transporter Imaging of Parkinsonian Syndromes

Phillip Kuo, MD, PhD

Phillip Kuo, MD, PhD

Questions and Answers, Coffee Service

PSMA PET Optimizing Therapy Response Assessment

Don C. Yoo, MD

Update on Nuclear Medicine for Infection and Inflammation

Don C. Yoo, MD

Amyloid and Tau Brain PET rebooted: The New Era of Neurotheranostics for Dementia

Phillip Kuo, MD, PhD

Discussion, Questions and Answers

October 17, 2025

Time

Session

Speaker

Check-In and Continental Breakfast, Mouton Meeting Room

Understanding the Role of PSMA-PET in Selecting Patients for PSMA-Targeted Therapy

Phillip Kuo, MD, PhD

Challenging and Instructive Abdomen and Pelvis PET/CT Rev

Don C. Yoo, MD

Questions and Answers, Coffee Service

Pearls and Pitfalls for FDG-PET

Phillip Kuo, MD, PhD

Don C. Yoo, MD

PET Imaging for the Differential Diagnosis of Dementia

Phillip Kuo, MD, PhD

Questions and Answers

Break for Lunch on Own

PET/CT Case Conference Greatest Hits

Andrew Quon, MD

Prostate Cancer PET Imaging Cases

Andrew Quon, MD

Nuclear Medicine Theranostics: From PET Scans to Therapy

Andrew Quon, MD

Discussion, Questions and Answers